Detalhe da pesquisa
1.
Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non-metastatic renal cell carcinoma: Systematic review and meta-analysis.
Int J Cancer
; 154(7): 1309-1323, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009868
2.
Other-cause mortality in incidental prostate cancer.
Prostate
; 84(8): 731-737, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506561
3.
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
N Engl J Med
; 384(22): 2102-2114, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077643
4.
Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data.
Cancer Immunol Immunother
; 73(2): 38, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289361
5.
Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma.
Ann Surg Oncol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773038
6.
Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve Replacement.
Ann Surg Oncol
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526833
7.
Assessing Functional Outcomes of Partial Versus Radical Nephrectomy for T1b-T2 Renal Masses: Results from a Multi-institutional Collaboration.
Ann Surg Oncol
; 2024 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38802714
8.
Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en-bloc transurethral resection.
Histopathology
; 85(1): 92-103, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477374
9.
Focal high-intensity focused ultrasound therapy for localized prostate cancer: An interim analysis of the multinational FASST study.
Eur J Clin Invest
; 54(6): e14192, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445798
10.
Comparison of discovery rates and prognostic utility of [68Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer-a cross-sectional study.
Eur J Nucl Med Mol Imaging
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38693454
11.
Addition of neoadjuvant chemotherapy to a 'quadrifecta' composite in radical cystectomy.
BJU Int
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483124
12.
Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis.
BJU Int
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658172
13.
Female non-obstetric urogenital fistula repair: long-term patient-reported outcomes and a scoping literature review.
BJU Int
; 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733321
14.
Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive bladder cancer.
BJU Int
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627025
15.
First-line immunotherapy of metastatic renal cell carcinoma: an updated network meta-analysis including triplet therapy.
BJU Int
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38659099
16.
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis.
BJU Int
; 133(3): 246-258, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562831
17.
Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancer.
BJU Int
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494989
18.
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer.
BJU Int
; 133(3): 341-350, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904652
19.
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer.
BJU Int
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470089
20.
Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment.
J Natl Compr Canc Netw
; : 1-7, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38838708